+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Animal Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 332 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5916050
The global revenue from the Animal Healthcare Market has surged to US$ 40 billion in 2024, with projections indicating that the market will attain a valuation of approximately US$ 58 billion by the end of 2031. The market's growth and future prospects are influenced by several critical factors.

Driving Growth: Development of Novel Vaccine Platforms and Regulatory Flexibility

Innovations in vaccine platforms are enhancing the effectiveness and precision of mass immunization. New systems, such as conveyor belt delivery of vaccines to day-old chicks and in-egg immunization of poultry, are boosting vaccination rates in the poultry industry. Oral vaccinations and automated injection devices are providing efficient protection in aquaculture, while autogenous vaccines are customizing protection for livestock based on specific strains of diseases. Regulatory flexibility can further expedite vaccine development and approvals, leading to more customized and efficient disease control solutions.

Challenges: Laborious Regulatory Approval Activity and Short Patent Protection Period

The animal healthcare industry faces challenges due to the lengthy and laborious regulatory approval process. Developing and gaining approval for new veterinary medicines and health products can take between five to fifteen years, further extending in Europe since 2015. The short patent protection period, especially in livestock, limits the time available for a return on investment. Differences in regulatory standards among regions, such as varying requirements for safety and efficacy trials, add complexity to product development and may hinder market entry, particularly in smaller markets.

Country-wise Insights

Booming U.S. Animal Healthcare Market: High Pet Ownership and Livestock Industry

The U.S. boasts a flourishing animal healthcare market, driven by a large number of companion animals, including cats, dogs, horses, birds, and fish, owned by over 67% of American households. Additionally, the livestock industry relies on veterinary medicines to ensure the health of animals used for food production, benefiting the national economy and food supply. These factors contribute to the market's growth, which is expected to continue in the coming years.

Lucrative Market in Germany: European Commission Guidelines and Reimbursements

Germany's animal healthcare market benefits from guidelines and reimbursements provided by the European Commission. The emphasis on public health, food safety, and the financial consequences of disease epidemics makes animal health a critical concern for European citizens. Equitable distribution of costs, rewards, and responsibilities plays a significant role in this, with governments involved in disease prevention and epidemic response. These factors drive market growth in Germany.

China's Emerging Prominence: Rising Investments in Animal Healthcare

China is emerging as a prominent market for animal healthcare due to regulatory changes that have both encouraged and challenged innovation. Increased transparency in policy-making and government initiatives to support the veterinary pharmaceutical industry have attracted multinational animal health companies to establish R&D and manufacturing operations in China. This trend has led to investments in the sector and the emergence of domestic players, solidifying China's position as a key market in the industry.

Competitive Landscape

Market consolidation is prompting top companies to focus on regional acquisitions, with Latin America and Asian countries like China and India witnessing notable activity. Key players with strong regional presence, direct sales forces, local GMP-certified production facilities, and skilled labor are leading the acquisition market.

Key Companies Covered

  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Virbac SA
  • Zoetis, Inc.
  • Hester Biosciences Ltd.
  • Intas Pharmaceuticals Ltd
  • Merck Animal Health
  • Elanco (Eli Lilly and Company)
  • Ceva Santé Animale
  • Alivira Animal Health Limited
  • Vetoquinol S.A.
  • Zydus Animal Health
  • Norbrook Laboratories Limited
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • Norbrook Laboratories, Inc

Key Segments Covered in Global Industry Research

Drugs:

  • Anti-Infective Agents
  • Antibiotics & Antimicrobials
  • Anti-Fungal
  • Anti-Viral
  • Anti-Inflammatory & Analgesic Agents
  • Parasiticides
  • Endo-Parasiticides
  • Ecto-Parasiticides
  • Endectocides
  • Vaccines
  • Hormones & Substitutes
  • Nutritional Products
  • Others

Animals:

  • Companion Animals
  • Cats
  • Dogs
  • Horse
  • Farm Animals
  • Ruminants
  • Swine
  • Poultry

Route of Administration:

  • Oral
  • Tablets/Capsules
  • Liquids
  • Powders/Premix
  • Others
  • Parenteral
  • Liquids
  • Powder for Injection
  • Topical
  • Solutions (Spot-on, Pour-on)
  • Creams & Ointments
  • Intramammary Preparations
  • Others
  • Others

Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Animal Healthcare Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Animal Healthcare Market Outlook, 2018 - 2031
3.1. Global Animal Healthcare Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Anti-Infective Agents
3.1.1.2. Antibiotics & Antimicrobials
3.1.1.3. Anti-Fungal
3.1.1.4. Anti-Viral Anti-Inflammatory & Analgesic Agents
3.1.1.5. Parasiticides
3.1.1.6. Vaccines
3.1.1.7. Hormones & Substitutes
3.1.1.8. Nutritional Products
3.1.1.9. Others
3.2. Global Animal Healthcare Market Outlook, by Animal, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Companion Animals
3.2.1.1.1. Cats
3.2.1.1.2. Dogs
3.2.1.1.3. Horse
3.2.1.2. Farm Animals
3.2.1.2.1. Ruminants
3.2.1.2.2. Swine
3.2.1.2.3. Poultry
3.3. Global Animal Healthcare Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Oral
3.3.1.2. Parenteral
3.3.1.3. Topical
3.3.1.4. Others
3.4. Global Animal Healthcare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Veterinary Hospitals
3.4.1.2. Veterinary Clinics
3.4.1.3. Pharmacies & Drug Stores
3.4.1.4. Others
3.5. Global Animal Healthcare Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Animal Healthcare Market Outlook, 2018 - 2031
4.1. North America Animal Healthcare Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Anti-Infective Agents
4.1.1.2. Antibiotics & Antimicrobials
4.1.1.3. Anti-Fungal
4.1.1.4. Anti-Viral Anti-Inflammatory & Analgesic Agents
4.1.1.5. Parasiticides
4.1.1.6. Vaccines
4.1.1.7. Hormones & Substitutes
4.1.1.8. Nutritional Products
4.1.1.9. Others
4.2. North America Animal Healthcare Market Outlook, by Animal, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Companion Animals
4.2.1.1.1. Cats
4.2.1.1.2. Dogs
4.2.1.1.3. Horse
4.2.1.2. Farm Animals
4.2.1.2.1. Ruminants
4.2.1.2.2. Swine
4.2.1.2.3. Poultry
4.3. North America Animal Healthcare Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Oral
4.3.1.2. Parenteral
4.3.1.3. Topical
4.3.1.4. Others
4.4. North America Animal Healthcare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Veterinary Hospitals
4.4.1.2. Veterinary Clinics
4.4.1.3. Pharmacies & Drug Stores
4.4.1.4. Others
4.5. North America Animal Healthcare Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
4.5.1.4. U.S. Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.5.1.5. Canada Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
4.5.1.6. Canada Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
4.5.1.7. Canada Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
4.5.1.8. Canada Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Animal Healthcare Market Outlook, 2018 - 2031
5.1. Europe Animal Healthcare Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Anti-Infective Agents
5.1.1.2. Antibiotics & Antimicrobials
5.1.1.3. Anti-Fungal
5.1.1.4. Anti-Viral Anti-Inflammatory & Analgesic Agents
5.1.1.5. Parasiticides
5.1.1.6. Vaccines
5.1.1.7. Hormones & Substitutes
5.1.1.8. Nutritional Products
5.1.1.9. Others
5.2. Europe Animal Healthcare Market Outlook, by Animal, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Companion Animals
5.2.1.1.1. Cats
5.2.1.1.2. Dogs
5.2.1.1.3. Horse
5.2.1.2. Farm Animals
5.2.1.2.1. Ruminants
5.2.1.2.2. Swine
5.2.1.2.3. Poultry
5.3. Europe Animal Healthcare Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Oral
5.3.1.2. Parenteral
5.3.1.3. Topical
5.3.1.4. Others
5.4. Europe Animal Healthcare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Veterinary Hospitals
5.4.1.2. Veterinary Clinics
5.4.1.3. Pharmacies & Drug Stores
5.4.1.4. Others
5.5. Europe Animal Healthcare Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
5.5.1.2. Germany Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
5.5.1.3. Germany Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.5.1.4. Germany Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.5. U.K. Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
5.5.1.6. U.K. Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
5.5.1.7. U.K. Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.5.1.8. U.K. Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.9. France Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
5.5.1.10. France Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
5.5.1.11. France Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.5.1.12. France Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.13. Italy Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
5.5.1.14. Italy Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
5.5.1.15. Italy Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.5.1.16. Italy Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.17. Turkey Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
5.5.1.18. Turkey Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
5.5.1.19. Turkey Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.5.1.20. Turkey Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.21. Russia Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
5.5.1.22. Russia Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
5.5.1.23. Russia Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.5.1.24. Russia Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.25. Rest of Europe Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
5.5.1.26. Rest of Europe Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
5.5.1.27. Rest of Europe Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.5.1.28. Rest of Europe Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Animal Healthcare Market Outlook, 2018 - 2031
6.1. Asia Pacific Animal Healthcare Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Anti-Infective Agents
6.1.1.2. Antibiotics & Antimicrobials
6.1.1.3. Anti-Fungal
6.1.1.4. Anti-Viral Anti-Inflammatory & Analgesic Agents
6.1.1.5. Parasiticides
6.1.1.6. Vaccines
6.1.1.7. Hormones & Substitutes
6.1.1.8. Nutritional Products
6.1.1.9. Others
6.2. Asia Pacific Animal Healthcare Market Outlook, by Animal, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Companion Animals
6.2.1.1.1. Cats
6.2.1.1.2. Dogs
6.2.1.1.3. Horse
6.2.1.2. Farm Animals
6.2.1.2.1. Ruminants
6.2.1.2.2. Swine
6.2.1.2.3. Poultry
6.3. Asia Pacific Animal Healthcare Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Oral
6.3.1.2. Parenteral
6.3.1.3. Topical
6.3.1.4. Others
6.4. Asia Pacific Animal Healthcare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Veterinary Hospitals
6.4.1.2. Veterinary Clinics
6.4.1.3. Pharmacies & Drug Stores
6.4.1.4. Others
6.5. Asia Pacific Animal Healthcare Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
6.5.1.2. China Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
6.5.1.3. China Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.5.1.4. China Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.5. Japan Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
6.5.1.6. Japan Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
6.5.1.7. Japan Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.5.1.8. Japan Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.9. South Korea Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
6.5.1.10. South Korea Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
6.5.1.11. South Korea Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.5.1.12. South Korea Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.13. India Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
6.5.1.14. India Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
6.5.1.15. India Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.5.1.16. India Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.17. Southeast Asia Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
6.5.1.18. Southeast Asia Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
6.5.1.19. Southeast Asia Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.5.1.20. Southeast Asia Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Animal Healthcare Market Outlook, 2018 - 2031
7.1. Latin America Animal Healthcare Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Anti-Infective Agents
7.1.1.2. Antibiotics & Antimicrobials
7.1.1.3. Anti-Fungal
7.1.1.4. Anti-Viral Anti-Inflammatory & Analgesic Agents
7.1.1.5. Parasiticides
7.1.1.6. Vaccines
7.1.1.7. Hormones & Substitutes
7.1.1.8. Nutritional Products
7.1.1.9. Others
7.2. Latin America Animal Healthcare Market Outlook, by Animal, Value (US$ Bn), 2018 - 2031
7.2.1.1. Companion Animals
7.2.1.1.1. Cats
7.2.1.1.2. Dogs
7.2.1.1.3. Horse
7.2.1.2. Farm Animals
7.2.1.2.1. Ruminants
7.2.1.2.2. Swine
7.2.1.2.3. Poultry
7.3. Latin America Animal Healthcare Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Oral
7.3.1.2. Parenteral
7.3.1.3. Topical
7.3.1.4. Others
7.4. Latin America Animal Healthcare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Veterinary Hospitals
7.4.1.2. Veterinary Clinics
7.4.1.3. Pharmacies & Drug Stores
7.4.1.4. Others
7.5. Latin America Animal Healthcare Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
7.5.1.2. Brazil Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
7.5.1.3. Brazil Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.5.1.4. Brazil Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.5. Mexico Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
7.5.1.6. Mexico Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
7.5.1.7. Mexico Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.5.1.8. Mexico Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.9. Argentina Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
7.5.1.10. Argentina Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
7.5.1.11. Argentina Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.5.1.12. Argentina Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.13. Rest of Latin America Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
7.5.1.14. Rest of Latin America Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
7.5.1.15. Rest of Latin America Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.5.1.16. Rest of Latin America Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Animal Healthcare Market Outlook, 2018 - 2031
8.1. Middle East & Africa Animal Healthcare Market Outlook, by Drug, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Anti-Infective Agents
8.1.1.2. Antibiotics & Antimicrobials
8.1.1.3. Anti-Fungal
8.1.1.4. Anti-Viral Anti-Inflammatory & Analgesic Agents
8.1.1.5. Parasiticides
8.1.1.6. Vaccines
8.1.1.7. Hormones & Substitutes
8.1.1.8. Nutritional Products
8.1.1.9. Others
8.2. Middle East & Africa Animal Healthcare Market Outlook, by Animal, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Companion Animals
8.2.1.1.1. Cats
8.2.1.1.2. Dogs
8.2.1.1.3. Horse
8.2.1.2. Farm Animals
8.2.1.2.1. Ruminants
8.2.1.2.2. Swine
8.2.1.2.3. Poultry
8.3. Middle East & Africa Animal Healthcare Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Oral
8.3.1.2. Parenteral
8.3.1.3. Topical
8.3.1.4. Others
8.4. Middle East & Africa Animal Healthcare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Veterinary Hospitals
8.4.1.2. Veterinary Clinics
8.4.1.3. Pharmacies & Drug Stores
8.4.1.4. Others
8.5. Middle East & Africa Animal Healthcare Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
8.5.1.2. GCC Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
8.5.1.3. GCC Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.5.1.4. GCC Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.5. South Africa Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
8.5.1.6. South Africa Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
8.5.1.7. South Africa Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.5.1.8. South Africa Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.9. Egypt Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
8.5.1.10. Egypt Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
8.5.1.11. Egypt Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.5.1.12. Egypt Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.13. Nigeria Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
8.5.1.14. Nigeria Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
8.5.1.15. Nigeria Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.5.1.16. Nigeria Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Animal Healthcare Market by Drug, Value (US$ Bn), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Animal Healthcare Market by Animal, Value (US$ Bn), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Animal Healthcare Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Animal Healthcare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Route of Administration vs By Animal Heatmap
9.2. Manufacturer vs By Animal Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Bayer AG
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Boehringer Ingelheim GmbH
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Virbac SA
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Zoetis, Inc.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Hester Biosciences Ltd.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Intas Pharmaceuticals Ltd
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Merck Animal Health
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Elanco (Eli Lilly and Company)
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Ceva Santé Animale
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Alivira Animal Health Limited
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Virbac SA
  • Zoetis, Inc.
  • Hester Biosciences Ltd.
  • Intas Pharmaceuticals Ltd
  • Merck Animal Health
  • Elanco (Eli Lilly and Company)
  • Ceva Santé Animale
  • Alivira Animal Health Limited
  • Vetoquinol S.A.
  • Zydus Animal Health
  • Norbrook Laboratories Limited
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • Norbrook Laboratories, Inc

Methodology

Loading
LOADING...